Zymeworks (ZYME)
(Delayed Data from NSDQ)
$10.40 USD
+0.02 (0.19%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $10.40 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Zymeworks Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -118.67 | 124.34 | -211.84 | -180.55 | -145.44 |
Depreciation/Amortization & Depletion | 10.16 | 12.00 | 9.58 | 10.28 | 7.33 |
Net Change from Assets/Liabilities | -25.55 | 4.01 | 0.39 | -10.15 | 6.44 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.75 | 3.75 | 9.42 | 29.02 | 49.81 |
Net Cash From Operating Activities | -118.30 | 144.11 | -192.45 | -151.40 | -81.85 |
Property & Equipment | -2.47 | -8.15 | -12.40 | -4.31 | -6.32 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -203.18 | -40.72 | 157.88 | -37.18 | -11.71 |
Other Investing Activities | -1.60 | -4.98 | -0.88 | -1.96 | -7.56 |
Net Cash from Investing Activities | -207.25 | -53.85 | 144.60 | -43.44 | -25.59 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 32.06 | 109.19 | 8.50 | 309.13 | 194.33 |
Issuance (Repayment) of Debt | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.02 | -0.01 | -0.02 | -0.04 | -0.02 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 49.86 | -0.60 | -0.47 | -0.11 | -0.65 |
Net Cash from Financing Activities | 81.85 | 108.58 | 8.01 | 308.98 | 193.66 |
Effect of Exchange Rate Changes | 0.35 | 0.20 | -0.33 | -0.55 | 0.03 |
Net Change In Cash & Equivalents | -243.36 | 199.05 | -40.17 | 113.59 | 86.25 |
Cash at Beginning of Period | 400.91 | 201.87 | 242.04 | 128.45 | 42.21 |
Cash at End of Period | 157.56 | 400.91 | 201.87 | 242.04 | 128.45 |
Diluted Net EPS | -1.72 | 1.90 | -4.61 | -3.58 | -3.83 |
Fiscal Year End for Zymeworks Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -31.65 | -118.67 | -104.19 | -75.51 |
Depreciation/Amortization & Depletion | NA | 2.31 | 10.16 | 13.96 | 7.42 |
Net Change from Assets/Liabilities | NA | -10.66 | -25.55 | -46.91 | -24.95 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 2.33 | 15.75 | 4.89 | 3.45 |
Net Cash From Operating Activities | NA | -37.67 | -118.30 | -132.26 | -89.59 |
Property & Equipment | NA | -0.19 | -2.47 | -2.12 | -1.19 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -6.66 | -203.18 | -203.59 | -197.71 |
Other Investing Activities | NA | -0.47 | -1.60 | -0.21 | 0.00 |
Net Cash from Investing Activities | NA | -7.32 | -207.25 | -205.92 | -198.90 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 2.13 | 32.06 | 31.29 | 29.38 |
Issuance (Repayment) of Debt | NA | 0.00 | -0.05 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | -0.01 | -0.02 | -0.01 | -0.01 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 49.86 | -0.04 | -0.03 |
Net Cash from Financing Activities | NA | 2.12 | 81.85 | 31.24 | 29.34 |
Effect of Exchange Rate Changes | NA | 0.12 | 0.35 | 0.36 | 0.33 |
Net Change In Cash & Equivalents | NA | -42.74 | -243.36 | -306.58 | -258.81 |
Cash at Beginning of Period | NA | 157.56 | 400.91 | 400.91 | 400.91 |
Cash at End of Period | NA | 114.81 | 157.56 | 94.33 | 142.10 |
Diluted Net EPS | NA | -0.42 | -0.18 | -0.41 | -0.76 |